THE SINGLE BEST STRATEGY TO USE FOR MENTAL HEALTH ASSESSMENT OF OLDER ADULTS

The makers of aducanumab are offered 6‐year approval through the FDA to deliver evidence of clinical profit. Tips for its acceptable use are beginning to be printedThe genetics of Alzheimer's sickness has seen big advancements in recent years. The fully penetrant mutations in 3 genes (amyloid precursor protein, presenilin 1 and presenilin 2), tha